Numico Research has developed a baby milk that, the company claims, strengthens the immune system and reduces the risk of infections and diarrhoea.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
A clinical trial with the formula, performed by Professor G. Moro of Macedonia Melloni Maternity Hospital in Milan, found that infants receiving Numico’s proprietary prebiotic infant formula show 60% less eczema compared with a classical HA-formula.
Based on the composition of breast milk, Numico Research has developed a proprietary prebiotic mixture of oligosaccharides that delivers the key benefits of breast milk for the development of the infant immune system, the company said. This specific prebiotic mixture is patent-protected.
